Breakthrough Research Offers New Hope in the Fight Against Lyme Disease Could relief be on the horizon for Lyme disease patients? New research has identified two drugs—cefotaxime and azlocillin—with the potential to revolutionize treatment for this debilitating condition. The findings, published in the journal Scientific Reports, have sparked

A new study in Connecticut found that nearly half of the deer ticks collected last year were infected with Lyme disease. Out of 2,068 deer ticks tested at the Center for Vector Biology and Zoonotic Diseases in New Haven, Connecticut, 46% carried the Lyme disease bacteria, Borrelia burgdorferi. Additionally,

For decades, Lyme disease treatments relied heavily on standard antibiotics, which usually tackle the infection. However, for up to 20% of those afflicted, these antibiotics fall short, leaving behind persistent symptoms like muscle pain, fatigue, and cognitive impairment that can last years—or even a lifetime. Enter a game-changing study